Waters Corporation (NYSE: WAT) today opened Pittcon 2015 by
showcasing its new capabilities and innovations that are driving
analytical science in exciting and novel directions.
"At Pittcon this year, we are showing customers how Waters'
innovations are opening doors to breakthrough solutions in Health
Science, breaking down barriers in biopharmaceutical manufacturing
processes, and reimagining laboratory data management," said Dr.
Rohit Khanna, Vice President of Worldwide Marketing for the Waters
Division. "These new capabilities and innovations are the result of
Waters' scientific focus, customer collaborations, and holistic
view to optimize every component of a solution: from hardware, to
software, to consumables, to service. That’s what it takes to keep
delivering 'The Science of What’s Possible.'"
Full Spectrum Molecular Imaging System
Leading Waters'® roster of new technologies is a new full
spectrum molecular imaging system, the first system ever to allow
scientists to access enhanced matrix-assisted laser desorption
ionization (MALDI) and desorption electrospray ionization (DESI)
with ion mobility separation (IMS) in a single mass spectrometry
platform.
Based on the Waters SYNAPT® G2-Si mass spectrometer, the imaging
capabilities of the new full spectrum molecular imaging system
enable research laboratories to pinpoint with greater specificity
the distribution of large and small molecules within tissue
samples. Information derived from imaging experiments can greatly
benefit cancer, cardiovascular and neuro-degenerative research by
measuring the distribution of molecules in cells and tissues. MS
imaging also allows researchers to identify different tissue types
based on their molecular composition.
“By combining MALDI with DESI and ion mobility on the same
instrument, Waters brings molecular imaging into a new realm,” said
Dr. Jeff Mazzeo, Sr. Director, Health Sciences, Waters Division.
“We are committed to giving cell biologists, biochemists, clinical
researchers and analytical scientists the tools they need to obtain
a maximum amount of information to advance their research into
human health. The new full spectrum molecular imaging system
combines and optimizes Waters' mass spectrometry technologies to
deliver a level of detail and molecular information beyond that of
any individual imaging technique."
Waters plans to begin shipments of its full spectrum molecular
imaging system in the third quarter of 2015.
NuGenesis Lab Management System
Now available, The NuGenesis® Lab Management System is a unique
and powerful alternative to a traditional Laboratory Information
Management System (LIMS) with advances that enable deeper insight
into scientific challenges, accelerated decision-making, better
business results and compliance with government regulations.
The NuGenesis Lab Management System offers high impact
functionality. New advances include NuGenesis SampleShare, an
optional, secure web-client for sample submissions and results
management; NuGenesis Stability, a complete stability protocol
management and testing solution to facilitate a consistent
regimented workflow across lab operations; NuGenesis Connectors, a
bi-directional link between lab systems and business applications,
and Paradigm™ Scientific Search, a fully integrated scientific
search solution for text, documents and science objects.
Uniquely combining data, workflow and sample management
capabilities to support the entire product lifecycle from discovery
through manufacturing, the NuGenesis Lab Management System is a
user-centric platform that encompasses a Scientific Data Management
System (SDMS), Electronic Laboratory Notebook (ELN) and Laboratory
Execution System (LES).
“The NuGenesis Lab Management System is more comprehensive than
anything in its class, combining new improvements with key existing
capabilities, minus the complex, costly and time-consuming
limitations associated with traditional LIMS,” said Garrett Mullen,
Senior Product Marketing Manager, Laboratory Management Informatics
at Waters Corporation. “It readily adapts to existing informatics
environments, smoothly linking data from the lab to the business
operations of a company enabling science-driven organizations can
see more, know more and do more.”
GlycoWorks™ RapiFluor-MS™ N-Glycan Kit
At WCBP 2015 in Washington DC, Waters announced ground-breaking
new technology for characterizing glycoproteins. The technology
includes the new GlycoWorks RapiFluor-MS N-Glycan Kit, the Waters
ACQUITY UPLC®, ACQUITY® UPLC FLR Detector and ACQUITY QDa®
detector, and enables scientists to analyze released N-glycans and
achieve new levels of speed, sensitivity and simplicity while
obtaining previously unattainable structural information.
This new suite of technologies enables fast de-glycosylation,
labeling and a workflow that reduces sample preparation time from a
day to less than one hour, allows mass detection for
characterization and development with sensitivity that is 100 to
1,000-fold better than current approaches, and enables routine
laboratory use supported by a simple robust protocol without
involving MS experts.
“(Today’s? – thought it was at WCBP) The new GlycoWorks
RapiFluor-MS N-Glycan Kit is a ground-breaking approach to glycan
analyses. It means scientists can monitor and characterize released
N-glycans like never before,” said Mike Yelle, Vice President,
Consumable Business Unit, Waters Division. “The new workflows take
what had been a specialized and complicated activity and transform
it into one which scientists and laboratories can be successful
with.”
ACQUITY UPC2 Trefoil and Torus Technology
Columns
Waters new analytical columns for chiral and achiral separations
are designed to optimize convergence chromatography. To address the
challenges of chiral separations, Waters ACQUITY UPC2® Trefoil™
Columns are 2.5 micron particle columns that increase speed and
selectivity while reducing method development time. Waters ACQUITY
UPC2 Torus™ Columns for achiral separations feature 1.7 micron
particle technology and deliver a new level of performance for
achiral SFC separations in terms of resolution, speed, selectivity
and robustness. The columns were introduced at SFC 2014 and are now
available for shipment worldwide.
These advanced columns are designed for use with the Waters
ACQUITY UPC2 System, a chromatographic system that takes advantage
of the power of non-toxic and inexpensive compressed carbon dioxide
as the primary mobile phase (carrier liquid) component. It is also
a “greener” alternative to expensive organic solvents. The
low-dispersion design of the ACQUITY UPC2 System combined with the
new columns offer chromatography laboratories a powerful, robust
and reliable analytical platform for increasing the speed with
which they can develop analytical methods, improve selectivity and
shorten run times, while at the same time reducing their carbon
footprint by transitioning to a greener technology. Since its
introduction in 2012, scientists using this system have authored
and published more than 80 articles in scientific journals.
“Waters continues to lead the way when it comes to making
convergence chromatography a powerful platform for robust
separations," said Michael Yelle, Vice President, Consumables
Business Unit, Waters Division. “The new Trefoil and Torus columns
represent a new paradigm in phases for carbon dioxide based
separations. Designed and optimized for Waters ACQUITY UPC2 system,
these columns deliver a new standard of performance in terms of the
robustness and reliability that scientists have come to expect from
analytical HPLC."
SFE Bio-Botanical Extraction System
Waters today announced the immediate availability of a new
ten-liter extraction vessel for its SFE Bio-Botanical Extraction
System, a multi-vessel supercritical fluid extraction (SFE) system
that rapidly fractionates and extracts large quantities of desired
components from a multitude of botanical matrices.
The ten-liter vessel doubles current capacity and can be
acquired as an add-on to installed systems. It will be available on
new systems in March 2015.
"As the extraction system of choice, the SFE Bio-Botanical
Extraction System provides high extraction efficiency and selective
fractionation of an extract in a single run," said Mark Groudas,
Vice President, Americas Field Operations, Waters Division. "The
drive to increase system capacity comes directly from our customers
who seek longer, unattended operation of their extraction
processes. As important as run time, users are seeing increased
consistency of final extracted products from run-to-run."
For More on Waters at Pittcon
For a comprehensive view of Waters' activities at the 2015
Pittsburgh Conference on Analytical Chemistry and Applied
Spectroscopy, including a full list of products, in-booth
activities and technical presentations, please visit
www.waters.com/pittcon.
About Waters Corporation (www.waters.com)
For more than 50 years, Waters Corporation has created business
advantages for laboratory-dependent organizations by delivering
practical and sustainable innovation to enable significant
advancements in such areas as healthcare delivery, environmental
management, food safety, water quality, consumer products and
high-value added chemicals worldwide.
Pioneering a connected portfolio of separations science,
laboratory information management, mass spectrometry and thermal
analysis, Waters’ technology breakthroughs and laboratory solutions
provide an enduring platform for customer success.
With revenue of $1.99 billion in 2014, Waters is driving
scientific discovery and operational excellence for customers
worldwide.
Waters, SYNAPT, ACQUITY, ACQUITY UPLC, ACQUITY UPC2, GlycoWorks,
RapiFluor-MS, NuGenesis, Trefoil, Torus, QDa and The Science of
What’s Possible.
Waters CorporationBrian J. Murphy, +1 508-482-2614Public
RelationsBrian_j_murphy@waters.com
Waters (NYSE:WAT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Waters (NYSE:WAT)
Historical Stock Chart
From Apr 2023 to Apr 2024